N. Zariffa

发表

Streamlining cardiovascular clinical trials to improve efficiency and generalisability

Deepak L. Bhatt, D. Madigan, M. Pfeffer, 2017, Heart.

A dose‐response study to assess the renal hemodynamic, vascular, and hormonal effects of eprosartan, an angiotensin II AT1‐receptor antagonist, in sodium‐replete healthy men

D. Jorkasky, M. Freed, N. Zariffa, 1998, Clinical pharmacology and therapeutics.

Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases.

J. Danesh, R. Collins, A. Hofman, 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Pharmacokinetics of Famciclovir in Subjects with Chronic Hepatic Disease

D. Jorkasky, M. Freed, N. Zariffa, 1994, Journal of clinical pharmacology.

Health data poverty: an assailable barrier to equitable digital health care.

Xiaoxuan Liu, A. Denniston, A. Morris, 2021, The Lancet. Digital health.

The Effect of Low‐Dose Cimetidine (200 mg Twice Daily) on the Pharmacokinetics of Theophylline

Jerome J. Schentag, D. Jorkasky, D. Nix, 1999, Journal of clinical pharmacology.

Comparative Effects of Nabumetone, Sulindac, and Indomethacin on Urinary Prostaglandin Excretion and Platelet Function in Volunteers

D. Jorkasky, D. Everitt, M. Freed, 1994, Journal of clinical pharmacology.

Data capture and sharing in the COVID-19 pandemic: a cause for concern

Jay J H Park, P. Arora, L. Dron, 2022, The Lancet Digital Health.

Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non–Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

G. Rosner, A. Chaudhuri, G. Pennello, 2022, JCO precision oncology.

Eprosartan Does Not Affect the Pharmacodynamics of Warfarin

D. Kazierad, D. Jorkasky, A. Forrest, 1998, Journal of clinical pharmacology.

Open Science to Address COVID-19: Sharing Data to Make Our Research Investment Go Further

F. Rockhold, J. Haggstrom, N. Zariffa, 2020, Therapeutic Innovation & Regulatory Science.

Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairment

D. Jorkasky, M. Freed, N. Zariffa, 1994, Clinical pharmacology and therapeutics.

Cardiovascular effects of i.v. granisetron at two administration rates and of ondansetron in healthy adults.

D. Jorkasky, N. Zariffa, B. Ilson, 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

The ABC of pharmaceutical trial design: some basic principles

S. Julious, N. Zariffa, N. Zariffa, 2002 .

Effect of Intravenous Fenoldopam on Intraocular Pressure in Ocular Hypertension

J. Piltz-seymour, D. Jorkasky, D. Everitt, 1997, Journal of clinical pharmacology.

Effect of age and gender on the pharmacokinetics of eprosartan.

D. Jorkasky, D. Tenero, N. Zariffa, 1998, British Journal of Clinical Pharmacology.

Pharmacokinetics of intravenously and orally administered eprosartan in healthy males: absolute bioavailability and effect of food

D. Jorkasky, D. Lundberg, D. Tenero, 1998, Biopharmaceutics & drug disposition.

Statistical Opportunities to Accelerate Development for COVID-19 Therapeutics

Samiran Ghosh, Fanni Natanegara, Névine Zariffa, 2020, Statistics in Biopharmaceutical Research.

Pharmacokinetics of Testosterone in Hypogonadal Men After Transdermal Delivery: Influence of Dose

D. Brocks, A. Meikle, N. Mazer, 1996, Journal of clinical pharmacology.

PhRMA Perspective on Population and Individual Bioequivalence

A. Gould, J. Barrett, A. Chow, 2000, Journal of clinical pharmacology.

Modeling and Interpreting QTc Prolongation in Clinical Pharmacology Studies

B. Jones, S. Patterson, N. Zariffa, 2005 .

Fenoldopam, a selective dopamine-1 receptor agonist, raises intraocular pressure in males with normal intraocular pressure.

D. Jorkasky, N. Shusterman, R. Stone, 1998, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Effects of Acetylsalicylic Acid on Inhibition of Ex Vivo Platelet Aggregation and Secretion by SKF 107260, a Novel GPIIb/IIIa Receptor Antagonist

D. Jorkasky, M. Freed, N. Zariffa, 1994, Thrombosis and Haemostasis.

Pharmacokinetics and Protein Binding of Eprosartan in Healthy Volunteers and in Patients with Varying Degrees of Renal Impairment

D. Jorkasky, D. Tenero, N. Zariffa, 1998, Journal of clinical pharmacology.